A Neu2 knockout mouse model showed that loss of NEU2 abrogates lipid metabolism, resulting in hypertriglyceridemia, fatty liver, impaired muscle differentiation and motor function, ultimately leading to obesity-like phenotypes [74]. Here, NEU2 is linked to hypertriglyceridemia.